FDA Investigator Brunilda Torres

Brunilda Torres has inspections in 18 countries as of 12 Oct 2023. Brunilda Torres has collaborated with a combinined 2385 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
205
Last Inspection Date:
12 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100004845
Country:
United States of America, United Kingdom of Great Britain and Northern Ireland, Romania, Brazil, India, France, Netherlands, Czechia, Mexico, Poland, Canada, Germany, Spain, Argentina, Norway, Chile, Denmark, Austria
Co-Investigator(s):
Albert A Salvador, Allen F Hall, Amanda J White, Ana Delp Cintron, Ana P Barido, Andrea H Norwood, Angela E Glenn, Ashley A Segura, Ashley B Jelonek, Barbara D Wright, Barbara M Frazier, Barbara T Carmichael, Betsy C Galliher, Borunild Torres, Branilde Torres, Brittny C Cargo, Brunidla Torres, Brutta Torres, Byungja E Marciante, Carl J Montgomery, Carla A Norris, CDR Ileana Barreto Pettit, CDR Sean T Creighton, Charles R Cote, RIC, Charles S Watson, Christine M Smith, Christopher T Smith, Chyla T Hunter, Clara E Santiago, Colleen M Aspinwall, Craig A Garmendia, David P King, Dawn M Mccabe, Deborah A Racioppi, Diana L Kelsch, Dianiris C Ayala, Douglas Florentino, Dr. Roy Blay, Dr. Sriram Subramaniam, PhD, Edward H Maticka, Edwards, Emily A Baldwin, Emily S Baldwin, Ethan P Stegman, Gabriel E Muniz, Gene R Gunn, German Rivera, Holly M Scott, Hunt, Israel Juarbe, Ivis Lnegron Torres, Jacqueline A O'shaughnessy, PhD, Jamie I Espinosa, Jana L Caylor, Jason D Tenney, Jennifer Alongie Vollom, Jennifer Lalama, Jennifer M Menendez, Jessica L Pressley, Joanne E King, John A Kadavil, PhD, John B Crowe, Jolanna A Norton, Jonathan R Campos, Jose M Gonzalez, Jose R Rodriguez, Joseph L Despins, PhD, Joshua J Silvestri, Juan C Gonzalez Rivera, Justin H Price, Karen M Cooper, Karen M Kondas, Karissa J Mccaw, Kelly I Anderson, Ladislav Kermet, Larry K Austin, Latrice G Jones, Laura B Kennedy, LCDR Angelica M Chica, LCDR Michael H Tollon, LCDR Randall L Morris, Leon L Crawley, Leslie A Cartmill, Linda K Matheny, Lindsay R Hatch, Lisa A Warner, Lourdes Valentin Aponte, LT Kimberly M Hull, LT Richard A Lyght, Luz I Collado, Madelyn Renteria, Margaret M Annes, Martin K Yau, PhD, Marybeth Willis, Matthew B Thomaston, Melanie M Walker, Mendoza, Meredith M Cobb, Michele M Falchek, Michelle S Dunaway, Nicole E Knowlton, Nilufer M Tampal, PhD, Ormond, Paul A Bonneau, Richard K Vogel, Robert C Steyert, Robert W Calais, Rodney W Lenger, Ronald T Weber, Ronnie E Jackson, Roy Bley, Ruth A Williams, Salvatore N Randazzo, Sarah Forney, Saundrea A Munroe, Shari H Shambaugh, Sharon K Thoma, PharmD, Sherbet L Samuels, Sheri L Stephenson, Sonia M Monges, Sripal R Mada, PhD, Stacey F Allard, Stacey F Rivette, State Agency, Stephanie C Milan, Susan M Turcovski, Teresa I Navas, Teresa M Hillebrandt, Terry G Forrest, Traci M Armand, Vernon L O'neil, Victor Spanioli, William D Tingley

Brunilda Torres's Documents

Publish Date Document Type Title
July, 2002 FDA 483 Lydia Corn, M.D. - Form 483, 2002-07-26
April, 2001 FDA 483 Ralph M. Vicari, MD - Form 483, 2001-04-12
May, 2010 FDA 483 Casale William, Md - Form 483, 2010-05-07
March, 2008 EIR Dr. Bruce G. Rankin, DO - EIR, 2008-03-12
September, 2001 EIR Larry I. Gilderman, D.O. - EIR, 2001-09-28
June, 2000 EIR M. Scholtes - EIR, 2000-06-30
April, 2000 EIR Jarl A. Kahn, M.D. - EIR, 2000-04-07
June, 2004 EIR Deepen Patel, M.D., C.C.F.P. - EIR, 2004-07-16
September, 2011 EIR Edouard R. Martin, M.D. - EIR, 2011-09-16
June, 2000 FDA 483 Response M. Scholtes - Form 483R, 2000-06-30
September, 2001 FDA 483 Response Larry I. Gilderman, D.O. - Form 483R, 2001-10-03
March, 2007 EIR Richmond, Gary J. MD - EIR, 2007-03-16
September, 2012 FDA 483 Pinsky Mark, MD - Form 483, 2012-09-28
April, 2006 FDA 483 Gerald Pierone, Jr., M.D. - Form 483, 2006-04-18
November, 2013 FDA 483 Weiner, Gilbert R. - Form 483, 2013-11-25
May, 2000 FDA 483 Gary DeVane, M.D. - Form 483, 2000-05-09
January, 2001 FDA 483 Rankin, Bruce, DO - Form 483, 2001-01-25
June, 2003 EIR Maxime Dougados, M.D. - EIR, 2003-06-27
November, 2013 EIR Weiner, Gilbert R. - EIR, 2013-11-25
March, 2007 FDA 483 Richmond, Gary J. MD - Form 483, 2007-03-16
December, 2004 FDA 483 Valjean Corporation - Form 483, 2004-12-16
June, 2009 EIR KForce Clinical Research, Inc. - EIR, 2009-06-11
April, 2000 FDA 483 Jarl A. Kahn, M.D. - Form 483, 2000-04-07
November, 2007 FDA 483 Chappel, Christopher, MD - Form 483, 2007-11-21
June, 2001 EIR Gerald Pierone, Jr., M.D. - EIR, 2001-06-22
September, 2000 FDA 483 Rakesh Prashad, M.D. - Form 483, 2000-09-14
February, 2002 FDA 483 Icon Laboratories - Form 483, 2002-02-11
June, 2003 FDA 483 Maxime Dougados, M.D. - Form 483, 2003-06-27
September, 2012 EIR Pinsky Mark, MD - EIR, 2012-09-28
April, 2010 FDA 483 Bramlet, Dale G. M.D. - Form 483, 2010-04-23
January, 2001 EIR Rankin, Bruce, DO - EIR, 2001-01-25
April, 2000 FDA 483 Baird, David, M.D. - Form 483, 2000-04-13
October, 2014 FDA 483 Marquez, Farid - Form 483, 2014-10-06
April, 2002 EIR Martin K. Dineen, M.D. - EIR, 2002-04-26
June, 2003 FDA 483 Response Gino J. Sedillo, M.D. - Form 483R, 2003-07-01
April, 2002 FDA 483 Response Covance Clinical Research Unit - Form 483R, 2002-05-08
February, 2000 EIR Paul K. Winner, D.O. - EIR, 2000-02-24
October, 2014 FDA 483 Response Marquez, Farid - Form 483R, 2014-10-23
June, 2003 EIR Gino J. Sedillo, M.D. - EIR, 2003-06-13
February, 2007 EIR Linda S. Harper, M.D. - EIR, 2007-02-21
June, 2000 FDA 483 C. Ron Williams, M.D. - Form 483, 2000-06-02
October, 2015 EIR Jose Giron - EIR, 2015-10-08
January, 2001 EIR Albert Razzetti, M.D. - EIR, 2001-01-25
June, 2009 FDA 483 KForce Clinical Research, Inc. - Form 483, 2009-06-11
February, 2000 EIR Paul K. Winner, D.O. - EIR, 2000-02-24
June, 2000 EIR Howard Offenberg, M.D. - EIR, 2000-06-19
October, 2015 FDA 483 Jose Giron - Form 483, 2015-10-08
February, 2009 FDA 483 Punjwani Sohail S., MD - Form 483, 2009-02-18
July, 2002 EIR Lydia Corn, M.D. - EIR, 2002-07-26
November, 2013 FDA 483 Response Weiner, Gilbert R. - Form 483R, 2013-12-03
June, 2004 EIR Francois Vallee, M.Sc. - EIR, 2004-07-27
February, 2009 FDA 483 Response Punjwani Sohail S., MD - Form 483R, 2009-03-13
March, 2013 FDA 483 Barbara A. Burtner - Form 483, 2013-03-20
September, 2000 EIR Rakesh Prashad, M.D. - EIR, 2000-09-14
February, 2003 FDA 483 Jeffrey L. Kugler, M.D. - Form 483, 2003-02-20
April, 2000 FDA 483 Response Baird, David, M.D. - Form 483R, 2000-08-04
June, 2001 FDA 483 Gerald Pierone, Jr., M.D. - Form 483, 2001-06-22
June, 2000 FDA 483 M. Scholtes - Form 483, 2000-06-30
January, 2003 EIR Linda S. Harper, M.D. - EIR, 2003-01-22
April, 2000 FDA 483 Response Jarl A. Kahn, M.D. - Form 483R, 2000-04-10
February, 2000 FDA 483 Paul K. Winner, D.O. - Form 483, 2000-02-24
April, 2015 FDA 483 Response Kayaleh Omar R. , MD - Form 483R, 2015-04-21
April, 2015 EIR Kayaleh Omar R. , MD - EIR, 2015-04-02
September, 2000 FDA 483 RESEARCH ASSOCIATES OF CENTRAL FLORIDA - Form 483, 2000-09-07
June, 2009 FDA 483 Response KForce Clinical Research, Inc. - Form 483R, 2009-07-01
November, 2000 EIR Thomas C. Marbury, M.D. - EIR, 2000-11-27
April, 2002 FDA 483 Covance Clinical Research Unit - Form 483, 2002-04-03
June, 2003 FDA 483 Gino J. Sedillo, M.D. - Form 483, 2003-06-20
November, 2007 EIR Chappel, Christopher, MD - EIR, 2007-11-21
May, 2000 EIR Gary DeVane, M.D. - EIR, 2000-05-09
April, 2015 FDA 483 Kayaleh Omar R. , MD - Form 483, 2015-04-02
April, 2000 EIR Baird, David, M.D. - EIR, 2000-06-09
June, 2000 EIR C. Ron Williams, M.D. - EIR, 2000-06-02
February, 2002 EIR Icon Laboratories - EIR, 2002-02-11

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more